Crescita to Acquire Strategic Assets of Occy Laboratory

Stock Information for Crescita Therapeutics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Crescita Therapeutics Inc

Crescita Reports Second Quarter 2024 Results
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World's Smallest Intradermal Delivery Device
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
Crescita Reports First Quarter 2024 Results
Crescita Reports Q4 and Fiscal 2023 Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.